Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
NEUROGENESIS |
333 |
1402 |
4.163e-39 |
1.937e-35 |
2 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
359 |
1672 |
1.942e-32 |
3.013e-29 |
3 |
CELL DEVELOPMENT |
320 |
1426 |
1.754e-32 |
3.013e-29 |
4 |
ORGAN MORPHOGENESIS |
216 |
841 |
3.787e-30 |
4.406e-27 |
5 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
202 |
788 |
4.266e-28 |
3.308e-25 |
6 |
CIRCULATORY SYSTEM DEVELOPMENT |
202 |
788 |
4.266e-28 |
3.308e-25 |
7 |
TISSUE DEVELOPMENT |
321 |
1518 |
1.212e-27 |
8.06e-25 |
8 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
215 |
872 |
2.117e-27 |
1.231e-24 |
9 |
REGULATION OF CELL DIFFERENTIATION |
316 |
1492 |
2.517e-27 |
1.301e-24 |
10 |
NEURON DIFFERENTIATION |
214 |
874 |
7.645e-27 |
3.557e-24 |
11 |
RESPONSE TO ENDOGENOUS STIMULUS |
307 |
1450 |
1.67e-26 |
7.062e-24 |
12 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
257 |
1142 |
3.469e-26 |
1.345e-23 |
13 |
HEAD DEVELOPMENT |
183 |
709 |
6.987e-26 |
2.501e-23 |
14 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
184 |
750 |
2.935e-23 |
9.753e-21 |
15 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
227 |
1008 |
3.42e-23 |
1.061e-20 |
16 |
REGULATION OF CELL DEVELOPMENT |
197 |
836 |
1.299e-22 |
3.777e-20 |
17 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
215 |
957 |
7.451e-22 |
2.039e-19 |
18 |
VASCULATURE DEVELOPMENT |
130 |
469 |
1.548e-21 |
4.002e-19 |
19 |
CELLULAR COMPONENT MORPHOGENESIS |
204 |
900 |
3.031e-21 |
7.423e-19 |
20 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
137 |
513 |
4.992e-21 |
1.161e-18 |
21 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
281 |
1395 |
7.206e-21 |
1.597e-18 |
22 |
NEURON DEVELOPMENT |
167 |
687 |
9.622e-21 |
1.947e-18 |
23 |
TISSUE MORPHOGENESIS |
140 |
533 |
9.477e-21 |
1.947e-18 |
24 |
NEURON PROJECTION DEVELOPMENT |
141 |
545 |
3.054e-20 |
5.921e-18 |
25 |
EMBRYO DEVELOPMENT |
200 |
894 |
3.769e-20 |
7.015e-18 |
26 |
CELL PROJECTION ORGANIZATION |
201 |
902 |
4.835e-20 |
8.653e-18 |
27 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
220 |
1021 |
5.456e-20 |
9.402e-18 |
28 |
HEART DEVELOPMENT |
126 |
466 |
6.471e-20 |
1.075e-17 |
29 |
EMBRYONIC MORPHOGENESIS |
139 |
539 |
7.791e-20 |
1.25e-17 |
30 |
FOREBRAIN DEVELOPMENT |
104 |
357 |
3.698e-19 |
5.735e-17 |
31 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
185 |
823 |
6.292e-19 |
9.444e-17 |
32 |
POSITIVE REGULATION OF GENE EXPRESSION |
324 |
1733 |
9.812e-19 |
1.427e-16 |
33 |
REGULATION OF NEURON DIFFERENTIATION |
139 |
554 |
1.056e-18 |
1.49e-16 |
34 |
REGULATION OF TRANSPORT |
334 |
1804 |
1.217e-18 |
1.666e-16 |
35 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
334 |
1805 |
1.329e-18 |
1.767e-16 |
36 |
NEURON PROJECTION MORPHOGENESIS |
111 |
402 |
2.011e-18 |
2.6e-16 |
37 |
UROGENITAL SYSTEM DEVELOPMENT |
91 |
299 |
2.812e-18 |
3.536e-16 |
38 |
INTRACELLULAR SIGNAL TRANSDUCTION |
298 |
1572 |
4.209e-18 |
5.001e-16 |
39 |
BIOLOGICAL ADHESION |
216 |
1032 |
4.299e-18 |
5.001e-16 |
40 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
329 |
1784 |
4.29e-18 |
5.001e-16 |
41 |
BLOOD VESSEL MORPHOGENESIS |
103 |
364 |
5.341e-18 |
6.061e-16 |
42 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
240 |
1192 |
7.616e-18 |
8.437e-16 |
43 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
159 |
689 |
1.661e-17 |
1.797e-15 |
44 |
SKELETAL SYSTEM DEVELOPMENT |
118 |
455 |
3.269e-17 |
3.457e-15 |
45 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
102 |
368 |
3.723e-17 |
3.849e-15 |
46 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
263 |
1360 |
3.896e-17 |
3.941e-15 |
47 |
RESPONSE TO HORMONE |
191 |
893 |
4.258e-17 |
4.132e-15 |
48 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
266 |
1381 |
4.262e-17 |
4.132e-15 |
49 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
326 |
1791 |
4.566e-17 |
4.249e-15 |
50 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
250 |
1275 |
4.516e-17 |
4.249e-15 |
51 |
REGULATION OF GTPASE ACTIVITY |
155 |
673 |
5.217e-17 |
4.76e-15 |
52 |
MORPHOGENESIS OF AN EPITHELIUM |
107 |
400 |
9.762e-17 |
8.735e-15 |
53 |
POSITIVE REGULATION OF CELL COMMUNICATION |
287 |
1532 |
9.972e-17 |
8.755e-15 |
54 |
SENSORY ORGAN DEVELOPMENT |
123 |
493 |
1.762e-16 |
1.519e-14 |
55 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
304 |
1656 |
1.929e-16 |
1.632e-14 |
56 |
TUBE DEVELOPMENT |
133 |
552 |
2.125e-16 |
1.766e-14 |
57 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
169 |
771 |
2.849e-16 |
2.325e-14 |
58 |
REGULATION OF DEVELOPMENTAL GROWTH |
85 |
289 |
3.598e-16 |
2.886e-14 |
59 |
CELL PART MORPHOGENESIS |
146 |
633 |
3.85e-16 |
3.036e-14 |
60 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
173 |
799 |
4.244e-16 |
3.291e-14 |
61 |
EPITHELIUM DEVELOPMENT |
196 |
945 |
4.616e-16 |
3.464e-14 |
62 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
297 |
1618 |
4.607e-16 |
3.464e-14 |
63 |
REGULATION OF CELL PROLIFERATION |
279 |
1496 |
5.186e-16 |
3.83e-14 |
64 |
REGULATION OF HYDROLASE ACTIVITY |
253 |
1327 |
9.904e-16 |
7.2e-14 |
65 |
RESPONSE TO GROWTH FACTOR |
118 |
475 |
1.032e-15 |
7.386e-14 |
66 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
162 |
740 |
1.375e-15 |
9.693e-14 |
67 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
328 |
1848 |
1.479e-15 |
1.027e-13 |
68 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
110 |
437 |
3.732e-15 |
2.554e-13 |
69 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
115 |
472 |
1.048e-14 |
7.069e-13 |
70 |
LOCOMOTION |
217 |
1114 |
1.36e-14 |
9.029e-13 |
71 |
TELENCEPHALON DEVELOPMENT |
70 |
228 |
1.378e-14 |
9.029e-13 |
72 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
276 |
1518 |
1.972e-14 |
1.275e-12 |
73 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
57 |
167 |
2.515e-14 |
1.603e-12 |
74 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
184 |
905 |
2.814e-14 |
1.769e-12 |
75 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
90 |
337 |
3.056e-14 |
1.896e-12 |
76 |
GROWTH |
103 |
410 |
3.262e-14 |
1.997e-12 |
77 |
DEVELOPMENTAL GROWTH |
89 |
333 |
4.048e-14 |
2.446e-12 |
78 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
127 |
552 |
4.154e-14 |
2.478e-12 |
79 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
195 |
983 |
5.514e-14 |
3.247e-12 |
80 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
301 |
1710 |
7.918e-14 |
4.605e-12 |
81 |
BEHAVIOR |
120 |
516 |
9.585e-14 |
5.506e-12 |
82 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
166 |
801 |
1.011e-13 |
5.736e-12 |
83 |
TUBE MORPHOGENESIS |
86 |
323 |
1.374e-13 |
7.705e-12 |
84 |
REGULATION OF SYSTEM PROCESS |
118 |
507 |
1.461e-13 |
8.091e-12 |
85 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
101 |
408 |
1.565e-13 |
8.568e-12 |
86 |
MULTICELLULAR ORGANISMAL SIGNALING |
46 |
123 |
1.792e-13 |
9.694e-12 |
87 |
REGULATION OF MEMBRANE POTENTIAL |
89 |
343 |
2.573e-13 |
1.376e-11 |
88 |
NEURON PROJECTION GUIDANCE |
63 |
205 |
2.725e-13 |
1.441e-11 |
89 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
55 |
166 |
2.894e-13 |
1.513e-11 |
90 |
SINGLE ORGANISM BEHAVIOR |
96 |
384 |
3.351e-13 |
1.732e-11 |
91 |
REGULATION OF ION TRANSPORT |
131 |
592 |
3.502e-13 |
1.791e-11 |
92 |
RESPONSE TO NITROGEN COMPOUND |
173 |
859 |
4.138e-13 |
2.093e-11 |
93 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
195 |
1004 |
4.428e-13 |
2.215e-11 |
94 |
REGULATION OF CELL PROJECTION ORGANIZATION |
125 |
558 |
4.984e-13 |
2.467e-11 |
95 |
ANGIOGENESIS |
79 |
293 |
6.668e-13 |
3.266e-11 |
96 |
GLAND DEVELOPMENT |
97 |
395 |
7.956e-13 |
3.856e-11 |
97 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
216 |
1152 |
8.705e-13 |
4.176e-11 |
98 |
EAR DEVELOPMENT |
60 |
195 |
9.44e-13 |
4.482e-11 |
99 |
MUSCLE STRUCTURE DEVELOPMENT |
103 |
432 |
1.107e-12 |
5.203e-11 |
100 |
REGULATION OF CELLULAR LOCALIZATION |
233 |
1277 |
1.885e-12 |
8.771e-11 |
101 |
POSITIVE REGULATION OF CELL PROLIFERATION |
163 |
814 |
3.329e-12 |
1.534e-10 |
102 |
EMBRYONIC ORGAN DEVELOPMENT |
97 |
406 |
4.465e-12 |
2.037e-10 |
103 |
RHYTHMIC PROCESS |
78 |
298 |
4.793e-12 |
2.152e-10 |
104 |
POSITIVE REGULATION OF TRANSPORT |
181 |
936 |
4.81e-12 |
2.152e-10 |
105 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
178 |
917 |
5.237e-12 |
2.321e-10 |
106 |
NEGATIVE REGULATION OF GENE EXPRESSION |
262 |
1493 |
5.787e-12 |
2.54e-10 |
107 |
ACTION POTENTIAL |
37 |
94 |
6.847e-12 |
2.977e-10 |
108 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
113 |
505 |
7.219e-12 |
3.11e-10 |
109 |
APPENDAGE DEVELOPMENT |
53 |
169 |
8.75e-12 |
3.701e-10 |
110 |
LIMB DEVELOPMENT |
53 |
169 |
8.75e-12 |
3.701e-10 |
111 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
31 |
70 |
8.918e-12 |
3.738e-10 |
112 |
SYNAPSE ORGANIZATION |
48 |
145 |
9.613e-12 |
3.994e-10 |
113 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
65 |
232 |
1.178e-11 |
4.849e-10 |
114 |
REGULATION OF CELL MORPHOGENESIS |
120 |
552 |
1.21e-11 |
4.941e-10 |
115 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
129 |
609 |
1.339e-11 |
5.419e-10 |
116 |
CELL MOTILITY |
164 |
835 |
1.439e-11 |
5.675e-10 |
117 |
LOCALIZATION OF CELL |
164 |
835 |
1.439e-11 |
5.675e-10 |
118 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
111 |
498 |
1.435e-11 |
5.675e-10 |
119 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
64 |
229 |
1.904e-11 |
7.446e-10 |
120 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
78 |
306 |
1.991e-11 |
7.722e-10 |
121 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
153 |
767 |
2.146e-11 |
8.254e-10 |
122 |
REGULATION OF HOMEOSTATIC PROCESS |
102 |
447 |
2.312e-11 |
8.817e-10 |
123 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
262 |
1517 |
3.292e-11 |
1.245e-09 |
124 |
RESPONSE TO ALCOHOL |
87 |
362 |
4.087e-11 |
1.534e-09 |
125 |
CHEMICAL HOMEOSTASIS |
168 |
874 |
4.812e-11 |
1.791e-09 |
126 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
59 |
207 |
4.862e-11 |
1.796e-09 |
127 |
REGULATION OF GROWTH |
131 |
633 |
4.92e-11 |
1.803e-09 |
128 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
49 |
156 |
4.966e-11 |
1.805e-09 |
129 |
REGULATION OF SECRETION |
141 |
699 |
5.984e-11 |
2.158e-09 |
130 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
118 |
554 |
7.061e-11 |
2.527e-09 |
131 |
REGULATION OF CELL DEATH |
254 |
1472 |
7.509e-11 |
2.667e-09 |
132 |
PALLIUM DEVELOPMENT |
48 |
153 |
8.171e-11 |
2.859e-09 |
133 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
97 |
426 |
8.12e-11 |
2.859e-09 |
134 |
CONNECTIVE TISSUE DEVELOPMENT |
56 |
194 |
8.756e-11 |
3.04e-09 |
135 |
GLAND MORPHOGENESIS |
36 |
97 |
9.595e-11 |
3.307e-09 |
136 |
RESPONSE TO PEPTIDE |
93 |
404 |
1.074e-10 |
3.675e-09 |
137 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
71 |
278 |
1.439e-10 |
4.887e-09 |
138 |
CELL CELL SIGNALING |
150 |
767 |
1.531e-10 |
5.163e-09 |
139 |
REGULATION OF AXONOGENESIS |
50 |
168 |
2.711e-10 |
9.074e-09 |
140 |
CEREBRAL CORTEX DEVELOPMENT |
37 |
105 |
2.991e-10 |
9.94e-09 |
141 |
STEM CELL DIFFERENTIATION |
54 |
190 |
3.562e-10 |
1.175e-08 |
142 |
MODULATION OF SYNAPTIC TRANSMISSION |
74 |
301 |
3.895e-10 |
1.276e-08 |
143 |
CELL CELL ADHESION |
124 |
608 |
4.304e-10 |
1.4e-08 |
144 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
71 |
285 |
4.726e-10 |
1.527e-08 |
145 |
RESPONSE TO LIPID |
166 |
888 |
5.713e-10 |
1.833e-08 |
146 |
REGULATION OF PEPTIDE SECRETION |
57 |
209 |
6.589e-10 |
2.1e-08 |
147 |
PROTEIN PHOSPHORYLATION |
174 |
944 |
6.642e-10 |
2.102e-08 |
148 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
319 |
1977 |
6.895e-10 |
2.168e-08 |
149 |
PATTERN SPECIFICATION PROCESS |
93 |
418 |
7.212e-10 |
2.252e-08 |
150 |
RESPONSE TO OXYGEN LEVELS |
75 |
311 |
7.595e-10 |
2.356e-08 |
151 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
252 |
1492 |
7.728e-10 |
2.381e-08 |
152 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
312 |
1929 |
8.425e-10 |
2.579e-08 |
153 |
POSITIVE REGULATION OF GROWTH |
62 |
238 |
8.931e-10 |
2.716e-08 |
154 |
ION TRANSPORT |
219 |
1262 |
1.053e-09 |
3.181e-08 |
155 |
EYE DEVELOPMENT |
77 |
326 |
1.253e-09 |
3.763e-08 |
156 |
NEURON MIGRATION |
37 |
110 |
1.342e-09 |
4.002e-08 |
157 |
METAL ION TRANSPORT |
118 |
582 |
1.652e-09 |
4.896e-08 |
158 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
193 |
1087 |
1.763e-09 |
5.191e-08 |
159 |
REGULATION OF EPITHELIAL CELL MIGRATION |
48 |
166 |
1.783e-09 |
5.218e-08 |
160 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
185 |
1036 |
2.488e-09 |
7.063e-08 |
161 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
99 |
465 |
2.49e-09 |
7.063e-08 |
162 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
185 |
1036 |
2.488e-09 |
7.063e-08 |
163 |
CELL FATE COMMITMENT |
59 |
227 |
2.486e-09 |
7.063e-08 |
164 |
REGULATION OF OSSIFICATION |
50 |
178 |
2.452e-09 |
7.063e-08 |
165 |
NEGATIVE REGULATION OF CELL DEATH |
161 |
872 |
2.633e-09 |
7.425e-08 |
166 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
100 |
472 |
2.716e-09 |
7.612e-08 |
167 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
51 |
184 |
2.818e-09 |
7.852e-08 |
168 |
RESPONSE TO ABIOTIC STIMULUS |
183 |
1024 |
2.868e-09 |
7.944e-08 |
169 |
EMBRYONIC ORGAN MORPHOGENESIS |
68 |
279 |
2.919e-09 |
8.035e-08 |
170 |
REGULATION OF HORMONE SECRETION |
65 |
262 |
3.035e-09 |
8.307e-08 |
171 |
REGULATION OF SYNAPSE ORGANIZATION |
37 |
113 |
3.124e-09 |
8.502e-08 |
172 |
MESENCHYME DEVELOPMENT |
52 |
190 |
3.201e-09 |
8.658e-08 |
173 |
OSSIFICATION |
63 |
251 |
3.241e-09 |
8.713e-08 |
174 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
72 |
303 |
3.258e-09 |
8.713e-08 |
175 |
CELLULAR RESPONSE TO PEPTIDE |
67 |
274 |
3.3e-09 |
8.775e-08 |
176 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
42 |
138 |
3.389e-09 |
8.96e-08 |
177 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
72 |
304 |
3.786e-09 |
9.953e-08 |
178 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
126 |
643 |
4.128e-09 |
1.079e-07 |
179 |
CARDIAC CHAMBER DEVELOPMENT |
43 |
144 |
4.22e-09 |
1.097e-07 |
180 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
110 |
541 |
5.027e-09 |
1.292e-07 |
181 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
110 |
541 |
5.027e-09 |
1.292e-07 |
182 |
CARDIAC CONDUCTION |
30 |
82 |
5.106e-09 |
1.305e-07 |
183 |
MUSCLE CELL DIFFERENTIATION |
60 |
237 |
5.381e-09 |
1.368e-07 |
184 |
REGULATION OF BLOOD CIRCULATION |
70 |
295 |
5.715e-09 |
1.445e-07 |
185 |
CAMP METABOLIC PROCESS |
18 |
34 |
6.007e-09 |
1.502e-07 |
186 |
REGULATION OF EXTENT OF CELL GROWTH |
34 |
101 |
6.036e-09 |
1.502e-07 |
187 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
59 |
232 |
6.007e-09 |
1.502e-07 |
188 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
40 |
131 |
7.161e-09 |
1.772e-07 |
189 |
REGULATION OF PEPTIDE TRANSPORT |
63 |
256 |
7.396e-09 |
1.821e-07 |
190 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
189 |
1079 |
7.717e-09 |
1.89e-07 |
191 |
CELLULAR RESPONSE TO LIPID |
96 |
457 |
8.857e-09 |
2.158e-07 |
192 |
SKELETAL SYSTEM MORPHOGENESIS |
53 |
201 |
9.29e-09 |
2.251e-07 |
193 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
88 |
408 |
1.002e-08 |
2.404e-07 |
194 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
44 |
153 |
1.002e-08 |
2.404e-07 |
195 |
REGIONALIZATION |
72 |
311 |
1.053e-08 |
2.513e-07 |
196 |
CELLULAR RESPONSE TO ACID CHEMICAL |
48 |
175 |
1.179e-08 |
2.798e-07 |
197 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
118 |
602 |
1.269e-08 |
2.998e-07 |
198 |
LOCOMOTORY BEHAVIOR |
49 |
181 |
1.326e-08 |
3.117e-07 |
199 |
SECOND MESSENGER MEDIATED SIGNALING |
45 |
160 |
1.453e-08 |
3.397e-07 |
200 |
MESENCHYMAL CELL DIFFERENTIATION |
40 |
134 |
1.464e-08 |
3.406e-07 |
201 |
INOSITOL LIPID MEDIATED SIGNALING |
38 |
124 |
1.513e-08 |
3.501e-07 |
202 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
53 |
204 |
1.607e-08 |
3.703e-07 |
203 |
REGULATION OF HEART CONTRACTION |
56 |
221 |
1.663e-08 |
3.811e-07 |
204 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
195 |
1135 |
2.042e-08 |
4.658e-07 |
205 |
RESPONSE TO STEROID HORMONE |
101 |
497 |
2.196e-08 |
4.984e-07 |
206 |
NEGATIVE REGULATION OF LOCOMOTION |
63 |
263 |
2.227e-08 |
5.031e-07 |
207 |
REGULATION OF HORMONE LEVELS |
98 |
478 |
2.248e-08 |
5.052e-07 |
208 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
24 |
60 |
2.29e-08 |
5.124e-07 |
209 |
REGULATION OF KINASE ACTIVITY |
143 |
776 |
2.379e-08 |
5.297e-07 |
210 |
POSITIVE REGULATION OF AXONOGENESIS |
26 |
69 |
2.617e-08 |
5.799e-07 |
211 |
REGULATION OF METAL ION TRANSPORT |
73 |
325 |
3.179e-08 |
7.011e-07 |
212 |
CELL PROLIFERATION |
127 |
672 |
3.335e-08 |
7.32e-07 |
213 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
86 |
406 |
3.521e-08 |
7.691e-07 |
214 |
REGULATION OF SYNAPSE ASSEMBLY |
28 |
79 |
3.66e-08 |
7.959e-07 |
215 |
TAXIS |
95 |
464 |
3.945e-08 |
8.539e-07 |
216 |
PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS |
21 |
49 |
4.087e-08 |
8.804e-07 |
217 |
POSITIVE REGULATION OF OSSIFICATION |
29 |
84 |
4.111e-08 |
8.816e-07 |
218 |
POSITIVE REGULATION OF LOCOMOTION |
88 |
420 |
4.153e-08 |
8.863e-07 |
219 |
TRANSMEMBRANE TRANSPORT |
188 |
1098 |
4.806e-08 |
1.016e-06 |
220 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
15 |
27 |
4.793e-08 |
1.016e-06 |
221 |
SENSORY ORGAN MORPHOGENESIS |
58 |
239 |
4.889e-08 |
1.029e-06 |
222 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
88 |
422 |
5.216e-08 |
1.093e-06 |
223 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
35 |
114 |
5.25e-08 |
1.095e-06 |
224 |
REGULATION OF CELL SIZE |
46 |
172 |
5.45e-08 |
1.132e-06 |
225 |
MUSCLE TISSUE DEVELOPMENT |
64 |
275 |
5.53e-08 |
1.144e-06 |
226 |
ADULT BEHAVIOR |
39 |
135 |
5.923e-08 |
1.219e-06 |
227 |
REGULATION OF NEURON DEATH |
60 |
252 |
6.026e-08 |
1.235e-06 |
228 |
KIDNEY EPITHELIUM DEVELOPMENT |
37 |
125 |
6.411e-08 |
1.308e-06 |
229 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
44 |
162 |
6.459e-08 |
1.312e-06 |
230 |
ODONTOGENESIS |
33 |
105 |
6.7e-08 |
1.355e-06 |
231 |
METANEPHROS DEVELOPMENT |
28 |
81 |
6.792e-08 |
1.362e-06 |
232 |
RESPONSE TO ESTROGEN |
54 |
218 |
6.766e-08 |
1.362e-06 |
233 |
REGULATION OF MAPK CASCADE |
124 |
660 |
6.834e-08 |
1.365e-06 |
234 |
REGULATION OF CELLULAR COMPONENT SIZE |
74 |
337 |
6.87e-08 |
1.366e-06 |
235 |
CATION TRANSPORT |
144 |
796 |
6.948e-08 |
1.376e-06 |
236 |
RESPONSE TO ACID CHEMICAL |
71 |
319 |
7.183e-08 |
1.416e-06 |
237 |
CARTILAGE DEVELOPMENT |
41 |
147 |
8.08e-08 |
1.586e-06 |
238 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
52 |
208 |
8.544e-08 |
1.67e-06 |
239 |
ION HOMEOSTASIS |
111 |
576 |
8.701e-08 |
1.694e-06 |
240 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
18 |
39 |
9.486e-08 |
1.839e-06 |
241 |
REGULATION OF NEURON APOPTOTIC PROCESS |
49 |
192 |
1.007e-07 |
1.944e-06 |
242 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
34 |
112 |
1.1e-07 |
2.115e-06 |
243 |
RESPONSE TO MECHANICAL STIMULUS |
52 |
210 |
1.19e-07 |
2.278e-06 |
244 |
SYNAPTIC SIGNALING |
87 |
424 |
1.321e-07 |
2.519e-06 |
245 |
RESPONSE TO DRUG |
88 |
431 |
1.411e-07 |
2.68e-06 |
246 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
13 |
22 |
1.43e-07 |
2.704e-06 |
247 |
FORELIMB MORPHOGENESIS |
18 |
40 |
1.535e-07 |
2.892e-06 |
248 |
MEMBRANE DEPOLARIZATION |
23 |
61 |
1.628e-07 |
3.055e-06 |
249 |
HEART MORPHOGENESIS |
52 |
212 |
1.647e-07 |
3.077e-06 |
250 |
BONE DEVELOPMENT |
42 |
156 |
1.663e-07 |
3.095e-06 |
251 |
WNT SIGNALING PATHWAY |
75 |
351 |
1.805e-07 |
3.346e-06 |
252 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
31 |
99 |
1.82e-07 |
3.347e-06 |
253 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
31 |
99 |
1.82e-07 |
3.347e-06 |
254 |
ARTERY DEVELOPMENT |
26 |
75 |
1.855e-07 |
3.368e-06 |
255 |
CYCLIC NUCLEOTIDE METABOLIC PROCESS |
22 |
57 |
1.86e-07 |
3.368e-06 |
256 |
SENSORY PERCEPTION OF PAIN |
26 |
75 |
1.855e-07 |
3.368e-06 |
257 |
NEURAL CREST CELL DIFFERENTIATION |
26 |
75 |
1.855e-07 |
3.368e-06 |
258 |
PALATE DEVELOPMENT |
28 |
85 |
2.169e-07 |
3.912e-06 |
259 |
NEPHRON DEVELOPMENT |
34 |
115 |
2.229e-07 |
4.004e-06 |
260 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
20 |
49 |
2.272e-07 |
4.066e-06 |
261 |
LIMBIC SYSTEM DEVELOPMENT |
31 |
100 |
2.343e-07 |
4.177e-06 |
262 |
RESPIRATORY SYSTEM DEVELOPMENT |
49 |
197 |
2.354e-07 |
4.18e-06 |
263 |
NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
36 |
126 |
2.551e-07 |
4.513e-06 |
264 |
REGULATION OF TRANSPORTER ACTIVITY |
49 |
198 |
2.775e-07 |
4.891e-06 |
265 |
REGULATION OF VASCULATURE DEVELOPMENT |
55 |
233 |
2.849e-07 |
5.002e-06 |
266 |
FAT CELL DIFFERENTIATION |
32 |
106 |
2.966e-07 |
5.188e-06 |
267 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
10 |
14 |
3.201e-07 |
5.579e-06 |
268 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
35 |
122 |
3.341e-07 |
5.8e-06 |
269 |
NEGATIVE REGULATION OF NEURON DEATH |
44 |
171 |
3.46e-07 |
5.985e-06 |
270 |
BRAIN MORPHOGENESIS |
16 |
34 |
3.528e-07 |
6.079e-06 |
271 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
21 |
55 |
4.361e-07 |
7.487e-06 |
272 |
POSITIVE REGULATION OF ION TRANSPORT |
55 |
236 |
4.426e-07 |
7.571e-06 |
273 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
66 |
303 |
4.694e-07 |
8e-06 |
274 |
REGULATION OF CELL SUBSTRATE ADHESION |
44 |
173 |
4.911e-07 |
8.31e-06 |
275 |
PHOSPHORYLATION |
201 |
1228 |
4.902e-07 |
8.31e-06 |
276 |
ION TRANSMEMBRANE TRANSPORT |
144 |
822 |
4.979e-07 |
8.394e-06 |
277 |
SYNAPSE ASSEMBLY |
24 |
69 |
5.076e-07 |
8.526e-06 |
278 |
ACTIN FILAMENT BASED PROCESS |
89 |
450 |
5.192e-07 |
8.69e-06 |
279 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
37 |
135 |
5.482e-07 |
9.142e-06 |
280 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
59 |
262 |
5.891e-07 |
9.755e-06 |
281 |
IN UTERO EMBRYONIC DEVELOPMENT |
67 |
311 |
5.876e-07 |
9.755e-06 |
282 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
32 |
109 |
5.963e-07 |
9.839e-06 |
283 |
CARDIAC CHAMBER MORPHOGENESIS |
31 |
104 |
6.161e-07 |
1.009e-05 |
284 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
31 |
104 |
6.161e-07 |
1.009e-05 |
285 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
27 |
84 |
6.189e-07 |
1.01e-05 |
286 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
67 |
312 |
6.637e-07 |
1.08e-05 |
287 |
REGULATION OF TRANSFERASE ACTIVITY |
161 |
946 |
6.734e-07 |
1.092e-05 |
288 |
COGNITION |
57 |
251 |
6.809e-07 |
1.1e-05 |
289 |
POSITIVE REGULATION OF SECRETION |
76 |
370 |
7.732e-07 |
1.245e-05 |
290 |
REGULATION OF CELL MATRIX ADHESION |
28 |
90 |
8.158e-07 |
1.309e-05 |
291 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
34 |
121 |
8.319e-07 |
1.33e-05 |
292 |
MUSCLE ORGAN DEVELOPMENT |
61 |
277 |
8.545e-07 |
1.362e-05 |
293 |
REGULATION OF PROTEIN LOCALIZATION |
161 |
950 |
8.764e-07 |
1.392e-05 |
294 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
38 |
143 |
9.019e-07 |
1.427e-05 |
295 |
NEUROMUSCULAR JUNCTION DEVELOPMENT |
16 |
36 |
9.281e-07 |
1.464e-05 |
296 |
REGULATION OF CELL GROWTH |
79 |
391 |
9.366e-07 |
1.472e-05 |
297 |
REGULATION OF ORGAN MORPHOGENESIS |
55 |
242 |
1.033e-06 |
1.618e-05 |
298 |
REGULATION OF HEART RATE |
27 |
86 |
1.044e-06 |
1.63e-05 |
299 |
PROTEIN LOCALIZATION |
277 |
1805 |
1.056e-06 |
1.643e-05 |
300 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
36 |
133 |
1.075e-06 |
1.667e-05 |
301 |
REGULATION OF MUSCLE SYSTEM PROCESS |
47 |
195 |
1.085e-06 |
1.677e-05 |
302 |
REGULATION OF WNT SIGNALING PATHWAY |
66 |
310 |
1.104e-06 |
1.7e-05 |
303 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
30 |
102 |
1.271e-06 |
1.952e-05 |
304 |
REGULATION OF BMP SIGNALING PATHWAY |
25 |
77 |
1.295e-06 |
1.981e-05 |
305 |
INNER EAR MORPHOGENESIS |
28 |
92 |
1.338e-06 |
2.041e-05 |
306 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
56 |
250 |
1.347e-06 |
2.048e-05 |
307 |
NEURON RECOGNITION |
15 |
33 |
1.431e-06 |
2.168e-05 |
308 |
TRANSMISSION OF NERVE IMPULSE |
20 |
54 |
1.44e-06 |
2.168e-05 |
309 |
OVULATION CYCLE |
32 |
113 |
1.436e-06 |
2.168e-05 |
310 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
16 |
37 |
1.457e-06 |
2.187e-05 |
311 |
REGULATION OF CELL ADHESION |
114 |
629 |
1.481e-06 |
2.216e-05 |
312 |
ORGAN GROWTH |
23 |
68 |
1.529e-06 |
2.272e-05 |
313 |
NERVE DEVELOPMENT |
23 |
68 |
1.529e-06 |
2.272e-05 |
314 |
RESPONSE TO ESTRADIOL |
38 |
146 |
1.571e-06 |
2.313e-05 |
315 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
38 |
146 |
1.571e-06 |
2.313e-05 |
316 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
112 |
616 |
1.563e-06 |
2.313e-05 |
317 |
MUSCLE SYSTEM PROCESS |
61 |
282 |
1.604e-06 |
2.354e-05 |
318 |
PHOSPHOLIPID METABOLIC PROCESS |
74 |
364 |
1.611e-06 |
2.358e-05 |
319 |
EPITHELIAL CELL DEVELOPMENT |
45 |
186 |
1.631e-06 |
2.379e-05 |
320 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
28 |
93 |
1.701e-06 |
2.468e-05 |
321 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
107 |
583 |
1.703e-06 |
2.468e-05 |
322 |
CELLULAR CHEMICAL HOMEOSTASIS |
105 |
570 |
1.785e-06 |
2.58e-05 |
323 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
80 |
404 |
1.832e-06 |
2.639e-05 |
324 |
CYCLIC NUCLEOTIDE MEDIATED SIGNALING |
18 |
46 |
1.899e-06 |
2.728e-05 |
325 |
POSITIVE REGULATION OF CELL DEATH |
110 |
605 |
1.934e-06 |
2.769e-05 |
326 |
RESPONSE TO INSULIN |
48 |
205 |
2.026e-06 |
2.892e-05 |
327 |
LIPID PHOSPHORYLATION |
29 |
99 |
2.08e-06 |
2.96e-05 |
328 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
17 |
42 |
2.1e-06 |
2.979e-05 |
329 |
RESPONSE TO KETONE |
44 |
182 |
2.163e-06 |
3.059e-05 |
330 |
MEMBRANE BIOGENESIS |
14 |
30 |
2.178e-06 |
3.07e-05 |
331 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
39 |
154 |
2.399e-06 |
3.373e-05 |
332 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
70 |
343 |
2.645e-06 |
3.707e-05 |
333 |
GLYCEROLIPID METABOLIC PROCESS |
72 |
356 |
2.695e-06 |
3.766e-05 |
334 |
MESONEPHROS DEVELOPMENT |
27 |
90 |
2.795e-06 |
3.894e-05 |
335 |
CARDIAC SEPTUM DEVELOPMENT |
26 |
85 |
2.843e-06 |
3.949e-05 |
336 |
EPITHELIAL CELL DIFFERENTIATION |
93 |
495 |
2.953e-06 |
4.089e-05 |
337 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
37 |
144 |
2.981e-06 |
4.117e-05 |
338 |
REPRODUCTION |
206 |
1297 |
2.991e-06 |
4.117e-05 |
339 |
REGULATION OF NEUROTRANSMITTER LEVELS |
45 |
190 |
3.014e-06 |
4.119e-05 |
340 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
33 |
122 |
3.019e-06 |
4.119e-05 |
341 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
45 |
190 |
3.014e-06 |
4.119e-05 |
342 |
CARDIAC VENTRICLE DEVELOPMENT |
30 |
106 |
3.067e-06 |
4.173e-05 |
343 |
MAMMARY GLAND DEVELOPMENT |
32 |
117 |
3.275e-06 |
4.443e-05 |
344 |
CARDIOCYTE DIFFERENTIATION |
28 |
96 |
3.403e-06 |
4.603e-05 |
345 |
NEGATIVE REGULATION OF CATALYTIC ACTIVITY |
141 |
829 |
3.476e-06 |
4.688e-05 |
346 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
84 |
437 |
3.518e-06 |
4.731e-05 |
347 |
EAR MORPHOGENESIS |
31 |
112 |
3.533e-06 |
4.737e-05 |
348 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
126 |
724 |
3.631e-06 |
4.855e-05 |
349 |
CIRCULATORY SYSTEM PROCESS |
73 |
366 |
3.895e-06 |
5.193e-05 |
350 |
REGULATION OF STEM CELL DIFFERENTIATION |
31 |
113 |
4.325e-06 |
5.75e-05 |
351 |
REGULATION OF ENERGY HOMEOSTASIS |
10 |
17 |
4.443e-06 |
5.89e-05 |
352 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
22 |
67 |
4.48e-06 |
5.922e-05 |
353 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
62 |
297 |
4.527e-06 |
5.967e-05 |
354 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
45 |
193 |
4.696e-06 |
6.159e-05 |
355 |
CALCIUM ION TRANSPORT |
50 |
223 |
4.712e-06 |
6.159e-05 |
356 |
DIENCEPHALON DEVELOPMENT |
24 |
77 |
4.708e-06 |
6.159e-05 |
357 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
29 |
103 |
4.984e-06 |
6.496e-05 |
358 |
HOMEOSTATIC PROCESS |
210 |
1337 |
5.137e-06 |
6.677e-05 |
359 |
MEMORY |
28 |
98 |
5.291e-06 |
6.857e-05 |
360 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
45 |
194 |
5.427e-06 |
7.012e-05 |
361 |
POSITIVE REGULATION OF AXON EXTENSION |
15 |
36 |
5.44e-06 |
7.012e-05 |
362 |
NEPHRON EPITHELIUM DEVELOPMENT |
27 |
93 |
5.566e-06 |
7.155e-05 |
363 |
REGULATION OF DENDRITE DEVELOPMENT |
32 |
120 |
5.876e-06 |
7.533e-05 |
364 |
POSITIVE REGULATION OF CELL GROWTH |
37 |
148 |
5.941e-06 |
7.594e-05 |
365 |
RENAL TUBULE DEVELOPMENT |
24 |
78 |
6.047e-06 |
7.709e-05 |
366 |
AMEBOIDAL TYPE CELL MIGRATION |
38 |
154 |
6.231e-06 |
7.921e-05 |
367 |
HINDBRAIN DEVELOPMENT |
35 |
137 |
6.265e-06 |
7.921e-05 |
368 |
MULTI MULTICELLULAR ORGANISM PROCESS |
48 |
213 |
6.255e-06 |
7.921e-05 |
369 |
REGULATION OF ION HOMEOSTASIS |
46 |
201 |
6.284e-06 |
7.924e-05 |
370 |
SPROUTING ANGIOGENESIS |
17 |
45 |
6.429e-06 |
8.062e-05 |
371 |
ENDOCHONDRAL BONE MORPHOGENESIS |
17 |
45 |
6.429e-06 |
8.062e-05 |
372 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
11 |
21 |
6.688e-06 |
8.365e-05 |
373 |
RESPONSE TO BMP |
27 |
94 |
6.942e-06 |
8.637e-05 |
374 |
CELLULAR RESPONSE TO BMP STIMULUS |
27 |
94 |
6.942e-06 |
8.637e-05 |
375 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
30 |
110 |
6.979e-06 |
8.659e-05 |
376 |
POST EMBRYONIC DEVELOPMENT |
26 |
89 |
7.279e-06 |
9.008e-05 |
377 |
PROSTATE GLAND DEVELOPMENT |
16 |
41 |
7.35e-06 |
9.071e-05 |
378 |
REGULATION OF NEUROTRANSMITTER TRANSPORT |
21 |
64 |
7.438e-06 |
9.155e-05 |
379 |
SECRETION |
105 |
588 |
7.496e-06 |
9.203e-05 |
380 |
RESPONSE TO INORGANIC SUBSTANCE |
89 |
479 |
7.568e-06 |
9.266e-05 |
381 |
BONE MORPHOGENESIS |
24 |
79 |
7.725e-06 |
9.434e-05 |
382 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
31 |
116 |
7.785e-06 |
9.458e-05 |
383 |
FEMALE SEX DIFFERENTIATION |
31 |
116 |
7.785e-06 |
9.458e-05 |
384 |
STRIATED MUSCLE CELL DIFFERENTIATION |
41 |
173 |
7.995e-06 |
9.688e-05 |
385 |
METENCEPHALON DEVELOPMENT |
28 |
100 |
8.094e-06 |
9.757e-05 |
386 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
28 |
100 |
8.094e-06 |
9.757e-05 |
387 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
15 |
37 |
8.156e-06 |
9.807e-05 |
388 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
44 |
191 |
8.281e-06 |
9.931e-05 |
389 |
REGULATION OF CYTOPLASMIC TRANSPORT |
89 |
481 |
8.965e-06 |
0.0001072 |
390 |
ENDOTHELIUM DEVELOPMENT |
26 |
90 |
9.101e-06 |
0.0001084 |
391 |
RESPONSE TO CARBOHYDRATE |
40 |
168 |
9.11e-06 |
0.0001084 |
392 |
HEART PROCESS |
25 |
85 |
9.509e-06 |
0.0001129 |
393 |
CAMERA TYPE EYE MORPHOGENESIS |
28 |
101 |
9.954e-06 |
0.0001179 |
394 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
23 |
75 |
9.985e-06 |
0.0001179 |
395 |
REGULATION OF SYNAPTIC PLASTICITY |
35 |
140 |
1.048e-05 |
0.0001232 |
396 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
35 |
140 |
1.048e-05 |
0.0001232 |
397 |
REGULATION OF NEUROTRANSMITTER SECRETION |
18 |
51 |
1.052e-05 |
0.0001234 |
398 |
DENDRITE MORPHOGENESIS |
16 |
42 |
1.058e-05 |
0.0001237 |
399 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
145 |
876 |
1.117e-05 |
0.0001303 |
400 |
CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION |
11 |
22 |
1.195e-05 |
0.000139 |
401 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
20 |
61 |
1.236e-05 |
0.0001434 |
402 |
DIVALENT INORGANIC CATION TRANSPORT |
56 |
268 |
1.246e-05 |
0.0001442 |
403 |
FOREBRAIN GENERATION OF NEURONS |
21 |
66 |
1.276e-05 |
0.0001473 |
404 |
REPLACEMENT OSSIFICATION |
12 |
26 |
1.352e-05 |
0.0001553 |
405 |
ENDOCHONDRAL OSSIFICATION |
12 |
26 |
1.352e-05 |
0.0001553 |
406 |
POSITIVE REGULATION OF HORMONE SECRETION |
31 |
119 |
1.363e-05 |
0.0001562 |
407 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
13 |
30 |
1.381e-05 |
0.0001579 |
408 |
EYE MORPHOGENESIS |
34 |
136 |
1.393e-05 |
0.0001588 |
409 |
REGULATION OF LIPID METABOLIC PROCESS |
58 |
282 |
1.446e-05 |
0.0001645 |
410 |
FOREBRAIN CELL MIGRATION |
20 |
62 |
1.624e-05 |
0.0001838 |
411 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
20 |
62 |
1.624e-05 |
0.0001838 |
412 |
PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS |
31 |
120 |
1.633e-05 |
0.0001844 |
413 |
COCHLEA DEVELOPMENT |
15 |
39 |
1.741e-05 |
0.0001952 |
414 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
15 |
39 |
1.741e-05 |
0.0001952 |
415 |
NEGATIVE CHEMOTAXIS |
15 |
39 |
1.741e-05 |
0.0001952 |
416 |
OSTEOBLAST DIFFERENTIATION |
32 |
126 |
1.749e-05 |
0.0001956 |
417 |
MONOVALENT INORGANIC CATION TRANSPORT |
81 |
435 |
1.762e-05 |
0.0001962 |
418 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
85 |
462 |
1.76e-05 |
0.0001962 |
419 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
30 |
115 |
1.81e-05 |
0.0002005 |
420 |
CELLULAR RESPONSE TO ALCOHOL |
30 |
115 |
1.81e-05 |
0.0002005 |
421 |
REGULATION OF INTRACELLULAR TRANSPORT |
108 |
621 |
1.833e-05 |
0.0002026 |
422 |
REGULATION OF CALCIUM ION TRANSPORT |
46 |
209 |
1.84e-05 |
0.0002029 |
423 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
44 |
197 |
1.889e-05 |
0.0002078 |
424 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
18 |
53 |
1.933e-05 |
0.0002117 |
425 |
CYTOSOLIC CALCIUM ION TRANSPORT |
18 |
53 |
1.933e-05 |
0.0002117 |
426 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
86 |
470 |
1.945e-05 |
0.0002125 |
427 |
HIPPOCAMPUS DEVELOPMENT |
22 |
73 |
2.101e-05 |
0.0002284 |
428 |
REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
22 |
73 |
2.101e-05 |
0.0002284 |
429 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS |
50 |
235 |
2.149e-05 |
0.0002331 |
430 |
RESPONSE TO EXTERNAL STIMULUS |
270 |
1821 |
2.166e-05 |
0.0002344 |
431 |
NEURON CELL CELL ADHESION |
9 |
16 |
2.247e-05 |
0.0002426 |
432 |
EPITHELIAL CELL PROLIFERATION |
25 |
89 |
2.285e-05 |
0.0002462 |
433 |
SECRETION BY CELL |
88 |
486 |
2.355e-05 |
0.000253 |
434 |
DENDRITE DEVELOPMENT |
23 |
79 |
2.558e-05 |
0.0002743 |
435 |
RESPONSE TO WOUNDING |
99 |
563 |
2.575e-05 |
0.0002754 |
436 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
47 |
218 |
2.63e-05 |
0.0002807 |
437 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
28 |
106 |
2.652e-05 |
0.0002824 |
438 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
22 |
74 |
2.66e-05 |
0.0002826 |
439 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
21 |
69 |
2.725e-05 |
0.0002889 |
440 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
20 |
64 |
2.742e-05 |
0.00029 |
441 |
OLFACTORY LOBE DEVELOPMENT |
14 |
36 |
2.861e-05 |
0.0003012 |
442 |
REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
14 |
36 |
2.861e-05 |
0.0003012 |
443 |
CELL SUBSTRATE ADHESION |
38 |
164 |
2.893e-05 |
0.0003039 |
444 |
ORGANOPHOSPHATE METABOLIC PROCESS |
144 |
885 |
2.904e-05 |
0.0003043 |
445 |
REGULATION OF BINDING |
57 |
283 |
3.206e-05 |
0.0003353 |
446 |
REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
17 |
50 |
3.221e-05 |
0.0003361 |
447 |
REGULATION OF POSITIVE CHEMOTAXIS |
11 |
24 |
3.377e-05 |
0.0003504 |
448 |
REGULATION OF FATTY ACID OXIDATION |
12 |
28 |
3.396e-05 |
0.0003504 |
449 |
IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY |
11 |
24 |
3.377e-05 |
0.0003504 |
450 |
NEURONAL ACTION POTENTIAL |
12 |
28 |
3.396e-05 |
0.0003504 |
451 |
MAMMARY GLAND DUCT MORPHOGENESIS |
12 |
28 |
3.396e-05 |
0.0003504 |
452 |
ENSHEATHMENT OF NEURONS |
25 |
91 |
3.451e-05 |
0.0003545 |
453 |
AXON ENSHEATHMENT |
25 |
91 |
3.451e-05 |
0.0003545 |
454 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
21 |
70 |
3.465e-05 |
0.0003552 |
455 |
AORTA DEVELOPMENT |
15 |
41 |
3.492e-05 |
0.0003563 |
456 |
GLUTAMATE RECEPTOR SIGNALING PATHWAY |
15 |
41 |
3.492e-05 |
0.0003563 |
457 |
MUSCLE CONTRACTION |
49 |
233 |
3.553e-05 |
0.0003614 |
458 |
GLIAL CELL DIFFERENTIATION |
33 |
136 |
3.558e-05 |
0.0003614 |
459 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
41 |
184 |
3.787e-05 |
0.0003839 |
460 |
REGULATION OF CELL CYCLE |
152 |
949 |
3.993e-05 |
0.0004039 |
461 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
32 |
131 |
4.031e-05 |
0.0004069 |
462 |
REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION |
44 |
203 |
4.091e-05 |
0.0004121 |
463 |
HINDLIMB MORPHOGENESIS |
14 |
37 |
4.106e-05 |
0.0004121 |
464 |
CELLULAR LIPID METABOLIC PROCESS |
147 |
913 |
4.109e-05 |
0.0004121 |
465 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
43 |
197 |
4.179e-05 |
0.0004181 |
466 |
GLIAL CELL DEVELOPMENT |
22 |
76 |
4.196e-05 |
0.0004189 |
467 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
27 |
103 |
4.244e-05 |
0.000422 |
468 |
REGULATION OF CALCIUM ION IMPORT |
27 |
103 |
4.244e-05 |
0.000422 |
469 |
CYCLIC NUCLEOTIDE CATABOLIC PROCESS |
9 |
17 |
4.275e-05 |
0.0004242 |
470 |
ARTERY MORPHOGENESIS |
17 |
51 |
4.306e-05 |
0.0004263 |
471 |
SENSORY PERCEPTION OF MECHANICAL STIMULUS |
36 |
155 |
4.394e-05 |
0.0004322 |
472 |
REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
36 |
155 |
4.394e-05 |
0.0004322 |
473 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
46 |
216 |
4.391e-05 |
0.0004322 |
474 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
18 |
56 |
4.49e-05 |
0.000439 |
475 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
18 |
56 |
4.49e-05 |
0.000439 |
476 |
OUTFLOW TRACT MORPHOGENESIS |
18 |
56 |
4.49e-05 |
0.000439 |
477 |
LIPID MODIFICATION |
45 |
210 |
4.515e-05 |
0.0004404 |
478 |
EMBRYONIC DIGIT MORPHOGENESIS |
19 |
61 |
4.549e-05 |
0.0004428 |
479 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
24 |
87 |
4.567e-05 |
0.0004436 |
480 |
KIDNEY MORPHOGENESIS |
23 |
82 |
4.909e-05 |
0.0004759 |
481 |
REGULATION OF EXOCYTOSIS |
41 |
186 |
4.921e-05 |
0.0004761 |
482 |
SODIUM ION TRANSPORT |
34 |
144 |
4.964e-05 |
0.0004792 |
483 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
49 |
236 |
5.012e-05 |
0.0004828 |
484 |
POSITIVE REGULATION OF KINASE ACTIVITY |
86 |
482 |
5.023e-05 |
0.0004828 |
485 |
GLYCEROLIPID BIOSYNTHETIC PROCESS |
45 |
211 |
5.095e-05 |
0.0004888 |
486 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
25 |
93 |
5.128e-05 |
0.0004899 |
487 |
POSITIVE REGULATION OF PEPTIDE SECRETION |
25 |
93 |
5.128e-05 |
0.0004899 |
488 |
CARDIAC MUSCLE CELL CONTRACTION |
12 |
29 |
5.174e-05 |
0.0004933 |
489 |
MEMBRANE ASSEMBLY |
11 |
25 |
5.39e-05 |
0.0005129 |
490 |
DEVELOPMENTAL MATURATION |
42 |
193 |
5.49e-05 |
0.0005213 |
491 |
ENDOTHELIAL CELL DIFFERENTIATION |
21 |
72 |
5.504e-05 |
0.0005216 |
492 |
OVULATION CYCLE PROCESS |
24 |
88 |
5.587e-05 |
0.0005273 |
493 |
REGULATION OF STEM CELL PROLIFERATION |
24 |
88 |
5.587e-05 |
0.0005273 |
494 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
14 |
5.666e-05 |
0.0005315 |
495 |
POSITIVE REGULATION OF FATTY ACID OXIDATION |
8 |
14 |
5.666e-05 |
0.0005315 |
496 |
CAMP CATABOLIC PROCESS |
8 |
14 |
5.666e-05 |
0.0005315 |
497 |
GLIOGENESIS |
39 |
175 |
5.764e-05 |
0.0005396 |
498 |
COLLAGEN FIBRIL ORGANIZATION |
14 |
38 |
5.801e-05 |
0.0005409 |
499 |
POSITIVE REGULATION OF ORGAN GROWTH |
14 |
38 |
5.801e-05 |
0.0005409 |
500 |
CARDIAC VENTRICLE MORPHOGENESIS |
19 |
62 |
5.842e-05 |
0.0005437 |
501 |
EMBRYONIC PLACENTA DEVELOPMENT |
23 |
83 |
6.043e-05 |
0.0005612 |
502 |
MUSCLE CELL DEVELOPMENT |
31 |
128 |
6.287e-05 |
0.0005827 |
503 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
28 |
111 |
6.504e-05 |
0.0006017 |
504 |
CRANIAL NERVE DEVELOPMENT |
15 |
43 |
6.634e-05 |
0.0006112 |
505 |
CEREBRAL CORTEX CELL MIGRATION |
15 |
43 |
6.634e-05 |
0.0006112 |
506 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
13 |
34 |
6.791e-05 |
0.000622 |
507 |
FOREBRAIN NEURON DEVELOPMENT |
13 |
34 |
6.791e-05 |
0.000622 |
508 |
RESPONSE TO FLUID SHEAR STRESS |
13 |
34 |
6.791e-05 |
0.000622 |
509 |
REGULATION OF ORGAN GROWTH |
21 |
73 |
6.879e-05 |
0.0006289 |
510 |
SPINAL CORD DEVELOPMENT |
27 |
106 |
7.281e-05 |
0.0006643 |
511 |
REGULATION OF CAMP METABOLIC PROCESS |
31 |
129 |
7.356e-05 |
0.0006698 |
512 |
EMBRYONIC PATTERN SPECIFICATION |
18 |
58 |
7.553e-05 |
0.0006864 |
513 |
REGULATION OF MUSCLE CONTRACTION |
34 |
147 |
7.715e-05 |
0.0006983 |
514 |
NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
12 |
30 |
7.703e-05 |
0.0006983 |
515 |
REGULATION OF JNK CASCADE |
36 |
159 |
7.729e-05 |
0.0006983 |
516 |
SEX DIFFERENTIATION |
53 |
266 |
8.023e-05 |
0.0007234 |
517 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
14 |
39 |
8.075e-05 |
0.0007239 |
518 |
REGULATION OF AXON GUIDANCE |
14 |
39 |
8.075e-05 |
0.0007239 |
519 |
TRABECULA MORPHOGENESIS |
14 |
39 |
8.075e-05 |
0.0007239 |
520 |
CALCIUM MEDIATED SIGNALING |
24 |
90 |
8.257e-05 |
0.0007389 |
521 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
38 |
172 |
8.666e-05 |
0.0007724 |
522 |
RESPONSE TO RETINOIC ACID |
27 |
107 |
8.66e-05 |
0.0007724 |
523 |
PLASMA MEMBRANE ORGANIZATION |
43 |
203 |
8.72e-05 |
0.0007758 |
524 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
104 |
616 |
8.797e-05 |
0.0007812 |
525 |
DIGESTIVE SYSTEM DEVELOPMENT |
34 |
148 |
8.9e-05 |
0.0007888 |
526 |
RESPONSE TO METAL ION |
63 |
333 |
9.018e-05 |
0.0007977 |
527 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
18 |
59 |
9.684e-05 |
0.0008544 |
528 |
RENAL SYSTEM PROCESS |
26 |
102 |
9.695e-05 |
0.0008544 |
529 |
ADULT LOCOMOTORY BEHAVIOR |
22 |
80 |
9.815e-05 |
0.0008617 |
530 |
INSULIN RECEPTOR SIGNALING PATHWAY |
22 |
80 |
9.815e-05 |
0.0008617 |
531 |
CIRCADIAN RHYTHM |
32 |
137 |
0.0001014 |
0.0008889 |
532 |
GASTRULATION |
35 |
155 |
0.0001022 |
0.0008936 |
533 |
CELLULAR HOMEOSTASIS |
112 |
676 |
0.0001055 |
0.0009207 |
534 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
21 |
75 |
0.0001057 |
0.0009213 |
535 |
REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
44 |
211 |
0.0001064 |
0.000924 |
536 |
SKIN DEVELOPMENT |
44 |
211 |
0.0001064 |
0.000924 |
537 |
OLFACTORY BULB INTERNEURON DIFFERENTIATION |
8 |
15 |
0.0001089 |
0.0009415 |
538 |
CELL COMMUNICATION BY ELECTRICAL COUPLING |
8 |
15 |
0.0001089 |
0.0009415 |
539 |
REGULATION OF CHEMOTAXIS |
39 |
180 |
0.0001098 |
0.0009475 |
540 |
MAMMARY GLAND MORPHOGENESIS |
14 |
40 |
0.0001109 |
0.0009535 |
541 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
14 |
40 |
0.0001109 |
0.0009535 |
542 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
82 |
465 |
0.0001117 |
0.0009589 |
543 |
POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
12 |
31 |
0.0001123 |
0.0009621 |
544 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
36 |
162 |
0.0001158 |
0.0009907 |
545 |
CELLULAR RESPONSE TO RETINOIC ACID |
19 |
65 |
0.0001188 |
0.001012 |
546 |
CALCIUM ION IMPORT |
19 |
65 |
0.0001188 |
0.001012 |
547 |
POSITIVE REGULATION OF RECEPTOR ACTIVITY |
15 |
45 |
0.0001201 |
0.001022 |
548 |
CYTOSKELETON ORGANIZATION |
134 |
838 |
0.000122 |
0.001036 |
549 |
AXIS ELONGATION |
11 |
27 |
0.000126 |
0.001068 |
550 |
LIPID METABOLIC PROCESS |
177 |
1158 |
0.0001295 |
0.001096 |
551 |
VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION |
9 |
19 |
0.0001303 |
0.001098 |
552 |
MULTICELLULAR ORGANISM GROWTH |
21 |
76 |
0.0001301 |
0.001098 |
553 |
CRANIAL NERVE MORPHOGENESIS |
10 |
23 |
0.0001338 |
0.001122 |
554 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
10 |
23 |
0.0001338 |
0.001122 |
555 |
INNERVATION |
10 |
23 |
0.0001338 |
0.001122 |
556 |
CELLULAR MACROMOLECULE LOCALIZATION |
187 |
1234 |
0.0001344 |
0.001124 |
557 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
13 |
36 |
0.0001348 |
0.001126 |
558 |
NEGATIVE REGULATION OF MAPK CASCADE |
33 |
145 |
0.0001357 |
0.001129 |
559 |
NEGATIVE REGULATION OF CELL CYCLE |
77 |
433 |
0.0001355 |
0.001129 |
560 |
FORMATION OF PRIMARY GERM LAYER |
27 |
110 |
0.0001431 |
0.001187 |
561 |
MECHANOSENSORY BEHAVIOR |
7 |
12 |
0.0001433 |
0.001187 |
562 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
7 |
12 |
0.0001433 |
0.001187 |
563 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
65 |
352 |
0.0001465 |
0.001211 |
564 |
REGULATION OF MULTICELLULAR ORGANISM GROWTH |
19 |
66 |
0.0001486 |
0.001224 |
565 |
LIPID BIOSYNTHETIC PROCESS |
92 |
539 |
0.0001484 |
0.001224 |
566 |
POSITIVE REGULATION OF CELL CYCLE |
62 |
332 |
0.0001491 |
0.001226 |
567 |
GOLGI TO PLASMA MEMBRANE TRANSPORT |
14 |
41 |
0.0001502 |
0.001233 |
568 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
34 |
152 |
0.0001546 |
0.001267 |
569 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
18 |
61 |
0.0001558 |
0.001274 |
570 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
21 |
77 |
0.0001593 |
0.001298 |
571 |
REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY |
21 |
77 |
0.0001593 |
0.001298 |
572 |
PROXIMAL DISTAL PATTERN FORMATION |
12 |
32 |
0.0001605 |
0.001301 |
573 |
EMBRYONIC FORELIMB MORPHOGENESIS |
12 |
32 |
0.0001605 |
0.001301 |
574 |
ADIPOSE TISSUE DEVELOPMENT |
12 |
32 |
0.0001605 |
0.001301 |
575 |
NEURAL CREST CELL MIGRATION |
16 |
51 |
0.0001621 |
0.001312 |
576 |
CALCIUM ION TRANSMEMBRANE TRANSPORT |
35 |
159 |
0.0001741 |
0.001406 |
577 |
RESPONSE TO FATTY ACID |
22 |
83 |
0.0001768 |
0.001425 |
578 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
19 |
67 |
0.0001848 |
0.001488 |
579 |
RIBONUCLEOTIDE CATABOLIC PROCESS |
11 |
28 |
0.0001855 |
0.001489 |
580 |
CAMP MEDIATED SIGNALING |
13 |
37 |
0.0001856 |
0.001489 |
581 |
NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION |
18 |
62 |
0.0001957 |
0.001556 |
582 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
8 |
16 |
0.0001952 |
0.001556 |
583 |
CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT |
8 |
16 |
0.0001952 |
0.001556 |
584 |
REGULATION OF TISSUE REMODELING |
18 |
62 |
0.0001957 |
0.001556 |
585 |
REGULATION OF FATTY ACID BETA OXIDATION |
8 |
16 |
0.0001952 |
0.001556 |
586 |
SINGLE ORGANISM CELL ADHESION |
80 |
459 |
0.0001984 |
0.001576 |
587 |
REGULATION OF BONE REMODELING |
14 |
42 |
0.0002011 |
0.001592 |
588 |
POSITIVE REGULATION OF GLUCOSE TRANSPORT |
14 |
42 |
0.0002011 |
0.001592 |
589 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
10 |
24 |
0.0002053 |
0.001619 |
590 |
CANONICAL WNT SIGNALING PATHWAY |
24 |
95 |
0.000205 |
0.001619 |
591 |
RESPONSE TO ETHANOL |
31 |
136 |
0.0002069 |
0.001629 |
592 |
POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION |
22 |
84 |
0.0002132 |
0.001676 |
593 |
EMBRYONIC EYE MORPHOGENESIS |
12 |
33 |
0.0002254 |
0.001768 |
594 |
REGULATION OF CELL JUNCTION ASSEMBLY |
19 |
68 |
0.0002285 |
0.00179 |
595 |
CELL MATRIX ADHESION |
28 |
119 |
0.0002347 |
0.001836 |
596 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
21 |
79 |
0.0002354 |
0.001838 |
597 |
NEGATIVE REGULATION OF TRANSFERASE ACTIVITY |
64 |
351 |
0.0002366 |
0.001844 |
598 |
RESPONSE TO ALKALOID |
31 |
137 |
0.0002377 |
0.00185 |
599 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
30 |
131 |
0.0002382 |
0.001851 |
600 |
REGULATION OF DENDRITE MORPHOGENESIS |
20 |
74 |
0.0002582 |
0.002002 |
601 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
16 |
53 |
0.0002667 |
0.002056 |
602 |
REGULATION OF MUSCLE CELL APOPTOTIC PROCESS |
14 |
43 |
0.0002662 |
0.002056 |
603 |
MESONEPHRIC TUBULE MORPHOGENESIS |
16 |
53 |
0.0002667 |
0.002056 |
604 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
11 |
29 |
0.0002673 |
0.002056 |
605 |
REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC |
11 |
29 |
0.0002673 |
0.002056 |
606 |
REGULATION OF LIPID KINASE ACTIVITY |
15 |
48 |
0.0002704 |
0.002069 |
607 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
15 |
48 |
0.0002704 |
0.002069 |
608 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
32 |
144 |
0.0002698 |
0.002069 |
609 |
PLACENTA DEVELOPMENT |
31 |
138 |
0.0002726 |
0.002083 |
610 |
DORSAL VENTRAL PATTERN FORMATION |
23 |
91 |
0.0002735 |
0.002086 |
611 |
TYPE B PANCREATIC CELL DEVELOPMENT |
7 |
13 |
0.0002789 |
0.002121 |
612 |
NEGATIVE REGULATION OF CARDIAC MUSCLE CELL APOPTOTIC PROCESS |
7 |
13 |
0.0002789 |
0.002121 |
613 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
24 |
97 |
0.0002877 |
0.002184 |
614 |
EPIDERMIS DEVELOPMENT |
49 |
253 |
0.000295 |
0.002232 |
615 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
87 |
514 |
0.0002945 |
0.002232 |
616 |
REGULATION OF CIRCADIAN RHYTHM |
25 |
103 |
0.0002987 |
0.002253 |
617 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
25 |
103 |
0.0002987 |
0.002253 |
618 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
33 |
151 |
0.0003023 |
0.002276 |
619 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM |
10 |
25 |
0.0003063 |
0.002302 |
620 |
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
20 |
75 |
0.0003136 |
0.002354 |
621 |
POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS |
30 |
133 |
0.0003148 |
0.002355 |
622 |
POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS |
30 |
133 |
0.0003148 |
0.002355 |
623 |
REGULATION OF PROTEIN SECRETION |
69 |
389 |
0.0003166 |
0.002364 |
624 |
REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL |
23 |
92 |
0.0003247 |
0.002421 |
625 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
52 |
274 |
0.0003281 |
0.002443 |
626 |
BRANCH ELONGATION OF AN EPITHELIUM |
8 |
17 |
0.0003308 |
0.002443 |
627 |
CAMP BIOSYNTHETIC PROCESS |
8 |
17 |
0.0003308 |
0.002443 |
628 |
ANATOMICAL STRUCTURE ARRANGEMENT |
8 |
17 |
0.0003308 |
0.002443 |
629 |
RESPONSE TO TOXIC SUBSTANCE |
47 |
241 |
0.0003294 |
0.002443 |
630 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
8 |
17 |
0.0003308 |
0.002443 |
631 |
POSITIVE REGULATION OF CELL ADHESION |
67 |
376 |
0.0003363 |
0.00248 |
632 |
VENTRICULAR SEPTUM DEVELOPMENT |
16 |
54 |
0.0003381 |
0.002489 |
633 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
24 |
98 |
0.0003391 |
0.002493 |
634 |
CARDIAC CELL DEVELOPMENT |
15 |
49 |
0.0003477 |
0.002552 |
635 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
27 |
116 |
0.000362 |
0.002653 |
636 |
POSITIVE REGULATION OF LIPID METABOLIC PROCESS |
29 |
128 |
0.0003633 |
0.002658 |
637 |
POSITIVE REGULATION OF HOMEOSTATIC PROCESS |
43 |
216 |
0.0003672 |
0.002682 |
638 |
NEGATIVE REGULATION OF AXONOGENESIS |
18 |
65 |
0.0003732 |
0.002722 |
639 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
11 |
30 |
0.0003775 |
0.002723 |
640 |
NEURON MATURATION |
11 |
30 |
0.0003775 |
0.002723 |
641 |
CEREBELLAR CORTEX MORPHOGENESIS |
11 |
30 |
0.0003775 |
0.002723 |
642 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
11 |
30 |
0.0003775 |
0.002723 |
643 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
11 |
30 |
0.0003775 |
0.002723 |
644 |
CELLULAR RESPONSE TO ESTRADIOL STIMULUS |
11 |
30 |
0.0003775 |
0.002723 |
645 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
11 |
30 |
0.0003775 |
0.002723 |
646 |
REGULATION OF CALCIUM MEDIATED SIGNALING |
20 |
76 |
0.0003792 |
0.002731 |
647 |
ACTIN FILAMENT BASED MOVEMENT |
23 |
93 |
0.000384 |
0.002757 |
648 |
REGULATION OF DNA BINDING |
23 |
93 |
0.000384 |
0.002757 |
649 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
24 |
99 |
0.0003984 |
0.002856 |
650 |
STEM CELL PROLIFERATION |
17 |
60 |
0.0004011 |
0.002871 |
651 |
EXOCYTOSIS |
57 |
310 |
0.0004053 |
0.002897 |
652 |
RECEPTOR METABOLIC PROCESS |
21 |
82 |
0.0004092 |
0.00292 |
653 |
REGULATION OF RECEPTOR ACTIVITY |
27 |
117 |
0.0004187 |
0.002979 |
654 |
SKIN EPIDERMIS DEVELOPMENT |
19 |
71 |
0.0004181 |
0.002979 |
655 |
POSITIVE REGULATION OF MAPK CASCADE |
80 |
470 |
0.0004241 |
0.003013 |
656 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
16 |
55 |
0.0004253 |
0.003016 |
657 |
POTASSIUM ION TRANSPORT |
33 |
154 |
0.0004402 |
0.003117 |
658 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
15 |
50 |
0.0004432 |
0.003128 |
659 |
LIPID LOCALIZATION |
50 |
264 |
0.0004437 |
0.003128 |
660 |
PROTEIN AUTOPHOSPHORYLATION |
39 |
192 |
0.0004436 |
0.003128 |
661 |
HEART TRABECULA MORPHOGENESIS |
10 |
26 |
0.0004455 |
0.003136 |
662 |
HINDBRAIN MORPHOGENESIS |
13 |
40 |
0.0004466 |
0.003139 |
663 |
SIGNAL RELEASE |
36 |
173 |
0.0004491 |
0.003152 |
664 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
18 |
66 |
0.0004574 |
0.003196 |
665 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
18 |
66 |
0.0004574 |
0.003196 |
666 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
18 |
66 |
0.0004574 |
0.003196 |
667 |
POSITIVE REGULATION OF CALCIUM ION TRANSPORT |
25 |
106 |
0.0004761 |
0.003321 |
668 |
REGENERATION |
34 |
161 |
0.0004818 |
0.003351 |
669 |
MONOCARBOXYLIC ACID TRANSPORT |
28 |
124 |
0.0004815 |
0.003351 |
670 |
REGULATION OF MAP KINASE ACTIVITY |
58 |
319 |
0.0004862 |
0.003376 |
671 |
NEGATIVE REGULATION OF TRANSPORT |
78 |
458 |
0.0004887 |
0.003389 |
672 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
17 |
61 |
0.0004958 |
0.003433 |
673 |
POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
7 |
14 |
0.0005012 |
0.00345 |
674 |
AMINO ACID BETAINE TRANSPORT |
7 |
14 |
0.0005012 |
0.00345 |
675 |
POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING |
7 |
14 |
0.0005012 |
0.00345 |
676 |
CRANIOFACIAL SUTURE MORPHOGENESIS |
7 |
14 |
0.0005012 |
0.00345 |
677 |
AORTA MORPHOGENESIS |
9 |
22 |
0.0005045 |
0.003467 |
678 |
POSITIVE REGULATION OF CAMP METABOLIC PROCESS |
22 |
89 |
0.0005129 |
0.00352 |
679 |
CARDIAC ATRIUM DEVELOPMENT |
11 |
31 |
0.0005233 |
0.003581 |
680 |
REGULATION OF SYNAPTIC VESICLE TRANSPORT |
11 |
31 |
0.0005233 |
0.003581 |
681 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC |
8 |
18 |
0.0005342 |
0.003618 |
682 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
158 |
1047 |
0.0005336 |
0.003618 |
683 |
GLANDULAR EPITHELIAL CELL DEVELOPMENT |
8 |
18 |
0.0005342 |
0.003618 |
684 |
SMOOTH MUSCLE TISSUE DEVELOPMENT |
8 |
18 |
0.0005342 |
0.003618 |
685 |
RESPONSE TO CAFFEINE |
8 |
18 |
0.0005342 |
0.003618 |
686 |
PERICARDIUM DEVELOPMENT |
8 |
18 |
0.0005342 |
0.003618 |
687 |
UTERUS DEVELOPMENT |
8 |
18 |
0.0005342 |
0.003618 |
688 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
43 |
220 |
0.0005493 |
0.003715 |
689 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
25 |
107 |
0.0005529 |
0.003734 |
690 |
CELLULAR RESPONSE TO FATTY ACID |
15 |
51 |
0.0005604 |
0.003779 |
691 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
13 |
41 |
0.0005842 |
0.003922 |
692 |
REGULATION OF MEMBRANE DEPOLARIZATION |
13 |
41 |
0.0005842 |
0.003922 |
693 |
CELLULAR RESPONSE TO ESTROGEN STIMULUS |
13 |
41 |
0.0005842 |
0.003922 |
694 |
VESICLE MEDIATED TRANSPORT |
183 |
1239 |
0.0005865 |
0.003932 |
695 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
207 |
1423 |
0.0005875 |
0.003933 |
696 |
SODIUM ION TRANSMEMBRANE TRANSPORT |
22 |
90 |
0.0006045 |
0.004041 |
697 |
NEGATIVE REGULATION OF MAP KINASE ACTIVITY |
19 |
73 |
0.0006098 |
0.004065 |
698 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
17 |
62 |
0.0006092 |
0.004065 |
699 |
POSITIVE REGULATION OF HEART GROWTH |
10 |
27 |
0.0006334 |
0.004198 |
700 |
DEVELOPMENTAL INDUCTION |
10 |
27 |
0.0006334 |
0.004198 |
701 |
HIPPO SIGNALING |
10 |
27 |
0.0006334 |
0.004198 |
702 |
SUBSTRATE DEPENDENT CELL MIGRATION |
10 |
27 |
0.0006334 |
0.004198 |
703 |
GLUCOSE HOMEOSTASIS |
35 |
170 |
0.0006562 |
0.004337 |
704 |
CARBOHYDRATE HOMEOSTASIS |
35 |
170 |
0.0006562 |
0.004337 |
705 |
AMMONIUM TRANSPORT |
16 |
57 |
0.0006587 |
0.004348 |
706 |
REGULATION OF CATABOLIC PROCESS |
115 |
731 |
0.0006709 |
0.004422 |
707 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
18 |
68 |
0.0006761 |
0.00445 |
708 |
NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY |
11 |
32 |
0.0007133 |
0.004662 |
709 |
SALIVARY GLAND DEVELOPMENT |
11 |
32 |
0.0007133 |
0.004662 |
710 |
METANEPHRIC NEPHRON DEVELOPMENT |
11 |
32 |
0.0007133 |
0.004662 |
711 |
POSITIVE REGULATION OF AMINE TRANSPORT |
11 |
32 |
0.0007133 |
0.004662 |
712 |
BLOOD VESSEL REMODELING |
11 |
32 |
0.0007133 |
0.004662 |
713 |
METANEPHRIC RENAL VESICLE MORPHOGENESIS |
6 |
11 |
0.0007205 |
0.004683 |
714 |
OPTIC NERVE DEVELOPMENT |
6 |
11 |
0.0007205 |
0.004683 |
715 |
NEGATIVE REGULATION OF ION TRANSPORT |
28 |
127 |
0.0007205 |
0.004683 |
716 |
OLFACTORY BULB INTERNEURON DEVELOPMENT |
6 |
11 |
0.0007205 |
0.004683 |
717 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
141 |
926 |
0.0007227 |
0.00469 |
718 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
27 |
121 |
0.000731 |
0.004737 |
719 |
PROSTATE GLAND MORPHOGENESIS |
9 |
23 |
0.0007427 |
0.00478 |
720 |
RESPONSE TO AUDITORY STIMULUS |
9 |
23 |
0.0007427 |
0.00478 |
721 |
TRABECULA FORMATION |
9 |
23 |
0.0007427 |
0.00478 |
722 |
POSITIVE REGULATION OF CYCLIC NUCLEOTIDE METABOLIC PROCESS |
25 |
109 |
0.0007396 |
0.00478 |
723 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE |
9 |
23 |
0.0007427 |
0.00478 |
724 |
NEUROEPITHELIAL CELL DIFFERENTIATION |
17 |
63 |
0.0007441 |
0.004782 |
725 |
NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
12 |
37 |
0.000751 |
0.00482 |
726 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
13 |
42 |
0.0007559 |
0.004845 |
727 |
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS |
96 |
595 |
0.0007925 |
0.005072 |
728 |
REGULATION OF ORGANELLE ORGANIZATION |
174 |
1178 |
0.0007938 |
0.005073 |
729 |
REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS |
21 |
86 |
0.000808 |
0.005154 |
730 |
MULTI ORGANISM REPRODUCTIVE PROCESS |
136 |
891 |
0.0008085 |
0.005154 |
731 |
POSITIVE REGULATION OF ANION TRANSPORT |
16 |
58 |
0.0008116 |
0.005166 |
732 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
8 |
19 |
0.0008279 |
0.005234 |
733 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION |
8 |
19 |
0.0008279 |
0.005234 |
734 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
32 |
153 |
0.0008261 |
0.005234 |
735 |
NEURONAL STEM CELL POPULATION MAINTENANCE |
8 |
19 |
0.0008279 |
0.005234 |
736 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
8 |
19 |
0.0008279 |
0.005234 |
737 |
REGULATION OF CYTOSKELETON ORGANIZATION |
83 |
502 |
0.0008353 |
0.005274 |
738 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
7 |
15 |
0.0008444 |
0.00531 |
739 |
REGULATION OF HEAT GENERATION |
7 |
15 |
0.0008444 |
0.00531 |
740 |
EPITHELIAL CELL FATE COMMITMENT |
7 |
15 |
0.0008444 |
0.00531 |
741 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
24 |
104 |
0.0008521 |
0.005351 |
742 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
15 |
53 |
0.0008751 |
0.00548 |
743 |
NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION |
15 |
53 |
0.0008751 |
0.00548 |
744 |
CELL ACTIVATION |
92 |
568 |
0.0008893 |
0.005562 |
745 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
51 |
279 |
0.0009084 |
0.005674 |
746 |
ORGANIC HYDROXY COMPOUND METABOLIC PROCESS |
80 |
482 |
0.0009157 |
0.005711 |
747 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
14 |
48 |
0.0009296 |
0.00579 |
748 |
NEGATIVE REGULATION OF JNK CASCADE |
11 |
33 |
0.0009573 |
0.005955 |
749 |
REGULATION OF GLYCOPROTEIN METABOLIC PROCESS |
13 |
43 |
0.0009681 |
0.005991 |
750 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
26 |
117 |
0.0009682 |
0.005991 |
751 |
CELL FATE DETERMINATION |
13 |
43 |
0.0009681 |
0.005991 |
752 |
REGULATION OF POLYSACCHARIDE METABOLIC PROCESS |
13 |
43 |
0.0009681 |
0.005991 |
753 |
NEURAL PRECURSOR CELL PROLIFERATION |
18 |
70 |
0.0009789 |
0.006049 |
754 |
CELL DEATH |
150 |
1001 |
0.0009873 |
0.006093 |
755 |
REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS |
16 |
59 |
0.0009937 |
0.006124 |
756 |
RESPONSE TO EXTRACELLULAR STIMULUS |
74 |
441 |
0.001027 |
0.006321 |
757 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
19 |
76 |
0.001038 |
0.006377 |
758 |
NEUROTRANSMITTER TRANSPORT |
32 |
155 |
0.001039 |
0.00638 |
759 |
REGULATION OF REGULATED SECRETORY PATHWAY |
28 |
130 |
0.001058 |
0.006483 |
760 |
REGULATION OF BODY FLUID LEVELS |
83 |
506 |
0.001062 |
0.006496 |
761 |
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
9 |
24 |
0.001065 |
0.006496 |
762 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
9 |
24 |
0.001065 |
0.006496 |
763 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
9 |
24 |
0.001065 |
0.006496 |
764 |
REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION |
26 |
118 |
0.001105 |
0.006723 |
765 |
MESODERM DEVELOPMENT |
26 |
118 |
0.001105 |
0.006723 |
766 |
REGULATION OF CATION CHANNEL ACTIVITY |
21 |
88 |
0.00111 |
0.006745 |
767 |
POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION |
35 |
175 |
0.001128 |
0.006845 |
768 |
REGULATION OF FAT CELL DIFFERENTIATION |
24 |
106 |
0.001132 |
0.006858 |
769 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
51 |
282 |
0.00116 |
0.007015 |
770 |
SYSTEM PROCESS |
251 |
1785 |
0.001161 |
0.007015 |
771 |
CARDIAC SEPTUM MORPHOGENESIS |
14 |
49 |
0.001162 |
0.007015 |
772 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
237 |
1676 |
0.001181 |
0.007118 |
773 |
LEARNING |
28 |
131 |
0.001197 |
0.007204 |
774 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
10 |
29 |
0.001206 |
0.00723 |
775 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
10 |
29 |
0.001206 |
0.00723 |
776 |
POTASSIUM ION IMPORT |
10 |
29 |
0.001206 |
0.00723 |
777 |
REGULATION OF GLUCOSE IMPORT |
16 |
60 |
0.001209 |
0.007232 |
778 |
CHONDROCYTE DIFFERENTIATION |
16 |
60 |
0.001209 |
0.007232 |
779 |
BODY MORPHOGENESIS |
13 |
44 |
0.001228 |
0.007316 |
780 |
POSITIVE REGULATION OF MUSCLE CONTRACTION |
13 |
44 |
0.001228 |
0.007316 |
781 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
13 |
44 |
0.001228 |
0.007316 |
782 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
89 |
552 |
0.001232 |
0.00733 |
783 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
8 |
20 |
0.001238 |
0.00734 |
784 |
AXONAL FASCICULATION |
8 |
20 |
0.001238 |
0.00734 |
785 |
RESPONSE TO OXIDATIVE STRESS |
61 |
352 |
0.001235 |
0.00734 |
786 |
RESPONSE TO CORTICOSTEROID |
35 |
176 |
0.001252 |
0.007413 |
787 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
11 |
34 |
0.001266 |
0.007475 |
788 |
REGULATION OF LIPASE ACTIVITY |
20 |
83 |
0.001269 |
0.007475 |
789 |
RENAL WATER HOMEOSTASIS |
11 |
34 |
0.001266 |
0.007475 |
790 |
REGULATION OF POTASSIUM ION TRANSPORT |
20 |
83 |
0.001269 |
0.007475 |
791 |
SEROTONIN METABOLIC PROCESS |
6 |
12 |
0.001298 |
0.007538 |
792 |
IMMUNE SYSTEM DEVELOPMENT |
93 |
582 |
0.001291 |
0.007538 |
793 |
VASCULAR SMOOTH MUSCLE CONTRACTION |
6 |
12 |
0.001298 |
0.007538 |
794 |
CELLULAR RESPONSE TO EPINEPHRINE STIMULUS |
6 |
12 |
0.001298 |
0.007538 |
795 |
SEGMENTATION |
21 |
89 |
0.001295 |
0.007538 |
796 |
ORGANOPHOSPHATE CATABOLIC PROCESS |
25 |
113 |
0.001282 |
0.007538 |
797 |
DISTAL TUBULE DEVELOPMENT |
6 |
12 |
0.001298 |
0.007538 |
798 |
POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION |
6 |
12 |
0.001298 |
0.007538 |
799 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
21 |
89 |
0.001295 |
0.007538 |
800 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
6 |
12 |
0.001298 |
0.007538 |
801 |
POSITIVE REGULATION OF GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS |
6 |
12 |
0.001298 |
0.007538 |
802 |
CELLULAR RESPONSE TO UV |
17 |
66 |
0.001312 |
0.007573 |
803 |
POSITIVE REGULATION OF INSULIN SECRETION |
17 |
66 |
0.001312 |
0.007573 |
804 |
MESODERM MORPHOGENESIS |
17 |
66 |
0.001312 |
0.007573 |
805 |
NEGATIVE REGULATION OF GROWTH |
44 |
236 |
0.001311 |
0.007573 |
806 |
REGULATION OF ANION TRANSPORT |
29 |
138 |
0.001307 |
0.007573 |
807 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
62 |
360 |
0.001325 |
0.007639 |
808 |
POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT |
7 |
16 |
0.001349 |
0.007751 |
809 |
RESPONSE TO EPINEPHRINE |
7 |
16 |
0.001349 |
0.007751 |
810 |
BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS |
7 |
16 |
0.001349 |
0.007751 |
811 |
MULTICELLULAR ORGANISM REPRODUCTION |
118 |
768 |
0.001377 |
0.007903 |
812 |
REGULATION OF ORGANIC ACID TRANSPORT |
14 |
50 |
0.001442 |
0.008263 |
813 |
HORMONE MEDIATED SIGNALING PATHWAY |
32 |
158 |
0.001449 |
0.008281 |
814 |
RESPONSE TO PURINE CONTAINING COMPOUND |
32 |
158 |
0.001449 |
0.008281 |
815 |
OVARIAN FOLLICLE DEVELOPMENT |
16 |
61 |
0.001463 |
0.008341 |
816 |
REGULATION OF EMBRYONIC DEVELOPMENT |
25 |
114 |
0.001463 |
0.008341 |
817 |
POSITIVE REGULATION OF PROTEIN COMPLEX DISASSEMBLY |
9 |
25 |
0.001492 |
0.008477 |
818 |
POSITIVE REGULATION OF LIPID CATABOLIC PROCESS |
9 |
25 |
0.001492 |
0.008477 |
819 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
9 |
25 |
0.001492 |
0.008477 |
820 |
SYNAPTIC VESICLE CYCLE |
21 |
90 |
0.001505 |
0.008541 |
821 |
PROTEIN UBIQUITINATION |
99 |
629 |
0.001511 |
0.008561 |
822 |
SMOOTH MUSCLE CONTRACTION |
13 |
45 |
0.001543 |
0.008725 |
823 |
RETINA MORPHOGENESIS IN CAMERA TYPE EYE |
13 |
45 |
0.001543 |
0.008725 |
824 |
REGULATION OF NOTCH SIGNALING PATHWAY |
17 |
67 |
0.001568 |
0.008855 |
825 |
POSITIVE REGULATION OF BINDING |
27 |
127 |
0.001575 |
0.008882 |
826 |
POSITIVE REGULATION OF CELL MATRIX ADHESION |
12 |
40 |
0.001619 |
0.009115 |
827 |
POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION |
10 |
30 |
0.00162 |
0.009115 |
828 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
63 |
370 |
0.001623 |
0.009118 |
829 |
REGULATION OF GLYCOGEN METABOLIC PROCESS |
11 |
35 |
0.001653 |
0.009232 |
830 |
CELLULAR RESPONSE TO KETONE |
18 |
73 |
0.001646 |
0.009232 |
831 |
CLATHRIN MEDIATED ENDOCYTOSIS |
11 |
35 |
0.001653 |
0.009232 |
832 |
EMBRYONIC CAMERA TYPE EYE DEVELOPMENT |
11 |
35 |
0.001653 |
0.009232 |
833 |
RESPONSE TO MONOAMINE |
11 |
35 |
0.001653 |
0.009232 |
834 |
RESPONSE TO CALCIUM ION |
25 |
115 |
0.001664 |
0.009283 |
835 |
NEUROMUSCULAR PROCESS |
22 |
97 |
0.001741 |
0.009702 |
836 |
POSITIVE REGULATION OF ORGANELLE ORGANIZATION |
91 |
573 |
0.001746 |
0.009717 |
837 |
REGULATION OF PHOSPHATASE ACTIVITY |
27 |
128 |
0.001776 |
0.00984 |
838 |
NEGATIVE REGULATION OF CHEMOTAXIS |
14 |
51 |
0.001776 |
0.00984 |
839 |
MECHANORECEPTOR DIFFERENTIATION |
14 |
51 |
0.001776 |
0.00984 |
840 |
PEPTIDYL TYROSINE MODIFICATION |
36 |
186 |
0.001771 |
0.00984 |
841 |
METANEPHRIC NEPHRON MORPHOGENESIS |
8 |
21 |
0.001796 |
0.009911 |
842 |
ORGANOPHOSPHATE BIOSYNTHETIC PROCESS |
74 |
450 |
0.001794 |
0.009911 |
843 |
REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS |
8 |
21 |
0.001796 |
0.009911 |